Skip to main content
Clinical Trials/NCT04036708
NCT04036708
Completed
N/A

Caregiver Early Child Development Training for Preventing Konzo From Toxic Cassava in the Democratic Republic of Congo (DRC)

Michigan State University1 site in 1 country238 target enrollmentApril 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Malnutrition
Sponsor
Michigan State University
Enrollment
238
Locations
1
Primary Endpoint
Mullen Scales of Early Learning (MSEL) Composite Score
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The proposed research adapted the caregiver training and child neurodevelopmental assessment capacity that the PI previously built in Uganda beginning in 2008, to a community-based intervention model for the prevention of konzo in the Democratic Republic of Congo.

Detailed Description

Early childhood (1 through 4 yrs) is a period of dramatic developmental change that can be seriously compromised by exposure to toxic cyanogenic cassava (konzo disease), with potentially great impact throughout central and western sub-Sahara Africa in regions dependent on this food staple. In the face of ongoing economic instability and nutritional, medical and educational deprivation affecting konzo at-risk communities in the Democratic Republic of Congo, no programs exist for sustaining a favorable developmental milieu for these children. By establishing the viability of caregiver training interventions to enhance functionality among caregivers and improve caregiving quality while preventing konzo, this research l can benefit tens of millions of children at-risk neurodevelopmentally; not only from poorly processed cyanogenic cassava, but also from a myriad of other non-infectious and infectious diseases.

Registry
clinicaltrials.gov
Start Date
April 1, 2021
End Date
August 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael J. Boivin

Professor and Director, Psychiatry Department Research Program

Michigan State University

Eligibility Criteria

Inclusion Criteria

  • Mother with at least one child aged between 1 and 4 years
  • Mother is the primary caregiver of child
  • Mother is 18 years of age or older

Exclusion Criteria

  • History of brain injury (infectious, traumatic, birth) in child
  • Konzo disease in any family member of household
  • Epilepsy in child
  • Any neurodisability in child
  • Caregiver is unable to participate in the year-long training

Outcomes

Primary Outcomes

Mullen Scales of Early Learning (MSEL) Composite Score

Time Frame: Month 6, month 12

The Mullen Scales of Early Learning (MSEL) assesses child developmental domains: visual reception, gross motor skills, fine motor skills, receptive language, and expressive language. A composite t-score derived from standardized t-scores of the four domains (excluding gross motor) provides a measure of g, the general measure of fluid intelligence thought to underlie general cognitive ability. The composite t-score ranges from 40 to 130. The t-scores have mean 100 and standard deviation 15 in the Western population. Higher scores reflect better outcome. Measure is applicable to children only, not collected from caregivers

Child Urine Thiocyanite Level

Time Frame: Month 6, month 12

Technicians collected samples of urine on the same day as child assessments, so that they are contiguous with level of cyanide exposure from current poorly processed cassava. Urine thiocyanite levels in urine were measured in micromol per liter. The range was 0-1032, higher scores reflect worse outcome. Data collected from children only, not collected from caregivers.

Secondary Outcomes

  • Home Observation for the Measurement of the Environment (HOME) Score(Month 6, month 12)
  • Child Physical Growth: Length for Age Z-score(Month 6, month 12)
  • Caregiver Anxiety Symptoms(Month 6, month 12)
  • Caregiver Depressive Symptoms(Month 6, month 12)
  • Child Physical Growth: Weight for Age Z-score(Month 6, month 12)

Study Sites (1)

Loading locations...

Similar Trials